Biosimilarity Assessment

Get In Touch

The development of biosimilars requires rigorous attention to the manufacturing process due to its impact on the characteristics of the final product. That’s because the process occurs in living cells, which are inherently variable. We’re highly experienced in this kind of assessment.

 

When it comes to the development of biosimilars, the originator’s manufacturing process typically remains proprietary information. Because of this, biosimilarity assessments are both challenging and critical to get right. This is a specialist skill, and something our consultants are highly adept at.

 

Experts in assessing ‘live’ manufacturing

 

Drawing on our extensive experience across numerous biosimilar projects, we’ll help you perform a robust assessment of all critical aspects of your biosimilar development, including:

  • Structural and functional analytics
  • Impurity controls
  • Pharmacokinetics / pharmacodynamics
  • Immunogenicity
  • Product formulation and presentation
  • Sensitivity of the above to changes that may be made in the manufacturing process
  • Overall integrated development strategy with tailored clinical development if needed, building on the totality of evidence

 

Get In Touch

Insights Hub

Sharing insights, questioning norms, asking the right questions - we'll never lose sight of what you're striving for. Our insight and expertise will help you bring the most innovative therapies within reach of patients around the world.
11.10.21
Christian Schneider

Biopharma’s Big Inflection Point: There’s never been a better time to innovate with next-generation medicine

by Christian K. Schneider, MD

In all of the years I have been tracking and helping to drive...

Start a conversation today

If you’re developing something truly ground-breaking, Biopharma Excellence is the nearest resource you’ll find to someone who’s been there before.

Socials: